{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:04:16Z","timestamp":1783926256612,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tjpad.2026.100626","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:51:35Z","timestamp":1781517095000},"page":"100626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond target engagement: RNA therapeutics and the neuroimmune challenge in tauopathies"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5809-7103","authenticated-orcid":false,"given":"Elizabeth Anne","family":"Breen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2026.100626_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2026.100585","article-title":"RNA-based therapeutics for Alzheimer's disease and related tauopathies: challenges and opportunities","volume":"13","author":"Rajbanshi","year":"2026","journal-title":"J Prev Alzheimers Dis"},{"issue":"794","key":"10.1016\/j.tjpad.2026.100626_bib0003","article-title":"Treating the immune system to repair the brain","volume":"18","author":"Schwartz","year":"2026","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.tjpad.2026.100626_bib0002","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease: a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"6640","key":"10.1016\/j.tjpad.2026.100626_bib0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo7649","article-title":"Transforming the understanding of brain immunity","volume":"380","author":"Castellani","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.tjpad.2026.100626_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-026-04433-3","article-title":"Genetic-exposome interactions and aging clocks in dementia: the ReDLat2 initiative","author":"Ib\u00e1\u00f1ez","year":"2026","journal-title":"Nat Med"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:04:41Z","timestamp":1783922681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2274580726001500"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100626","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond target engagement: RNA therapeutics and the neuroimmune challenge in tauopathies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100626"}}